These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Influence of the CYP4F2 polymorphism on the risk of hemorrhagic complications in coumarin-treated patients. Chen P; Sun YQ; Yang GP; Li R; Pan J; Zhou YS Saudi Med J; 2016 Apr; 37(4):361-8. PubMed ID: 27052278 [TBL] [Abstract][Full Text] [Related]
47. A RARE COMPLICATION OF COUMARIN-CONGENER ANTICOAGULANT THERAPY. MAYER GA Can Med Assoc J; 1965 Aug; 93(8):370. PubMed ID: 14339300 [No Abstract] [Full Text] [Related]
49. [Mumps in a 80-year-old patient?]. Batard-Pampuch B Praxis (Bern 1994); 2008 Feb; 97(4):205-7. PubMed ID: 18548802 [TBL] [Abstract][Full Text] [Related]
50. The presence of microcalculi in normal human submandibular and parotid salivary glands. Epivatianos A; Harrison JD Arch Oral Biol; 1989; 34(4):261-5. PubMed ID: 2597019 [TBL] [Abstract][Full Text] [Related]
52. Coumarin congeners in the etiology of hemorrhagic necrosis of the skin. Barron RL; Knox JC J Am Osteopath Assoc; 1967 Oct; 67(2):63-9. PubMed ID: 5183264 [No Abstract] [Full Text] [Related]
53. Prolonged anticoagulation therapy adjunctive to aspirin after successful fibrinolysis: from early reduction in reocclusion to improved long-term clinical outcome. van den Bergh PJ; Kievit PC; Brouwer MA; Aengevaeren WR; Veen G; Verheugt FW Am Heart J; 2009 Mar; 157(3):532-40. PubMed ID: 19249425 [TBL] [Abstract][Full Text] [Related]
54. [Drug interactions in coumarin anticoagulation]. Kessler P Vnitr Lek; 1999 Aug; 45(8):490-5. PubMed ID: 11045152 [TBL] [Abstract][Full Text] [Related]
55. Patient self-monitoring of oral anticoagulant therapy: potential benefits and implications for clinical practice. Douketis JD Am J Cardiovasc Drugs; 2001; 1(4):245-51. PubMed ID: 14728024 [TBL] [Abstract][Full Text] [Related]
56. Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis. Gonzalez-Fajardo JA; Arreba E; Castrodeza J; Perez JL; Fernandez L; Agundez I; Mateo AM; Carrera S; Gutiérrez V; Vaquero C J Vasc Surg; 1999 Aug; 30(2):283-92. PubMed ID: 10436448 [TBL] [Abstract][Full Text] [Related]
57. Coumarin-induced skin necrosis following heparin-induced thrombocytopenia and thrombosis. A case report. Shahak A; Pósán E; Szücs G; Rigó J; Boda Z Angiology; 1996 Jul; 47(7):725-7. PubMed ID: 8686970 [TBL] [Abstract][Full Text] [Related]
58. A rare complication of coumarin-congener anticoagulant therapy. Mayer GA Can Med Assoc J; 1965 Nov; 93(19):1042-3. PubMed ID: 5890639 [No Abstract] [Full Text] [Related]
59. Intramural hematoma of the esophagus as a complication of anticoagulant or antiplatelet therapy. Efe C; Ozseker B; Kav T; Harmanci O; Bayraktar Y Scand J Gastroenterol; 2011 Nov; 46(11):1399-400. PubMed ID: 21644848 [No Abstract] [Full Text] [Related]
60. [Cholesterol emboli during coumarin therapy]. Lüftl M; Schuler G; Simon M J Dtsch Dermatol Ges; 2003 May; 1(5):378-80. PubMed ID: 16285304 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]